FIELD: medicine. SUBSTANCE: the present innovation deals with elaborating the formulas of solutions applied in conducting the so-called "open heart" operations. Polyionic buffer cardioplegic solution has got osmolarity of 350±5 mOsm, contains sodium chloride, potassium chloride, calcium chloride, magnesium chloride, potassium asparaginate, magnesium asparaginate, mannitol, trisamine and water for injections at the following ratio of components, weight%: sodium chloride 0.63-0.77, potassium chloride 0.027-0.033, magnesium hexachloride 0.18-0.22, calcium hexachloride 0.009-0.011, potassium semi-water asparaginate 0.20-0.24, magnesium tetraasparaginate 0.17-0.19, mannitol 0.32-0.38, trisamine 0.05-0.07, water for injections the rest, moreover, pH of solution corresponds to 7,6±0,1 at 22 C. Composition of "Infusol" provides sufficient improvement in restoring the function and metabolism of heart at reperfusion after stoppage of artificial circulation. EFFECT: higher efficiency. 1 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
CRYSTALLOID CARDIOPLEGIC SOLUTIONS, CONTAINING DODECAPEPTIDES (VERSIONS) | 2013 |
|
RU2549470C1 |
CARDIOPLEGIA AGENT (VERSIONS) | 2014 |
|
RU2568911C1 |
CRYSTALLOID CARDIOPLEGIC SOLUTION | 2009 |
|
RU2423135C2 |
METHOD FOR RESTORING HEART CONTRACTILITY AFTER CARDIOPLEGIA WITH CALCIUM ANTAGONISTS IN EXPERIMENT | 1996 |
|
RU2133612C1 |
WATER-SOLUBLE COMPOSITION, POSSESSIVE PROPERTIES OF CARDIO-PROTECTOR | 2010 |
|
RU2438698C1 |
METHOD FOR CARDIOPLEGIC ARREST (VERSIONS) | 2015 |
|
RU2571058C1 |
METHOD OF CARDIOPLEGIC ANTEGRADE MYOCARDIAL PROTECTION | 2022 |
|
RU2803867C1 |
ASN-BOKERIYA-BOLDYREV CARDIOPLEGIC SOLUTION | 2009 |
|
RU2413502C1 |
METHOD FOR EVALUATING THE STATE OF MYOCARDIUM IN CARDIOSURGICAL INTERVENTIONS UNDER CONDITIONS OF CARDIOPLEGIC PROTECTION | 2017 |
|
RU2651364C1 |
NASAL MEDICINE MORENAZAL | 2007 |
|
RU2369397C2 |
Authors
Dates
2004-03-27—Published
2002-11-05—Filed